Not applicableStudy completedNCT03841266What this trial is testingRecurrence Risk Evaluation by 21-gene DetectionWho this might be right forRelationship and Consistency Analysis Xijing Hospital 220
Large-scale testing (Phase 3)UnknownNCT02344472What this trial is testingDetect V / CHEVENDO (Chemo vs. Endo)Who this might be right forMetastatic Breast Cancer Prof. Wolfgang Janni 271
Testing effectiveness (Phase 2)Looking for participantsNCT07180160What this trial is testingIparomlimab and Tuvonralimab (QL1706) in Patients With HR-positive, HER2-negative Advanced Breast CancerWho this might be right forAdvanced Breast Cancer Wenjin Yin 123
Testing effectiveness (Phase 2)Active Not RecruitingNCT04316117What this trial is testingUsing FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE StudyWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Hormone Receptor Positive Breast CarcinomaMetastatic Breast Carcinoma+1 more ECOG-ACRIN Cancer Research Group 138
Testing effectiveness (Phase 2)Ended earlyNCT01151215What this trial is testingStudy of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast CancerWho this might be right forNeoplasmsBreast NeoplasmsBreast Cancer AstraZeneca 482
Not applicableLooking for participantsNCT07617025What this trial is testingPrognostic and Predictive Role of Intrinsic Molecular Subtypes in BRCA-associated Breast CancerWho this might be right forBreast Cancer Angela Toss 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05090358What this trial is testingPreventing High Blood Sugar in People Being Treated for Metastatic Breast CancerWho this might be right forBreast CancerBreast Cancer Stage IVMetastatic Breast Cancer Memorial Sloan Kettering Cancer Center 15
Not applicableStudy completedNCT00072293What this trial is testingSurgical Resection With or Without Axillary Lymph Node Dissection in Treating Women With Node-Negative Breast Cancer and Sentinel Lymph Node MicrometastasesWho this might be right forBreast Cancer ETOP IBCSG Partners Foundation 931
Not applicableUnknownNCT01655004What this trial is testingProspective Study of UDP-gluconoryltransferase 2B17 Genotype as a Predictive Marker of Exemestane PK and PDWho this might be right forBreast Carcinoma National University Hospital, Singapore 110
Not applicableStudy completedNCT01384838What this trial is testingExercise Training in Postmenopausal Patients With Breast CancerWho this might be right forPhysical Activity Arbeitsgemeinschaft medikamentoese Tumortherapie 80
Testing effectiveness (Phase 2)UnknownNCT00687648What this trial is testingCyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast CancerWho this might be right forBreast Cancer National Cancer Centre, Singapore 70
Testing effectiveness (Phase 2)Looking for participantsNCT05766410What this trial is testingStudy Comparing the Immune Modulation Effect of Ribociclib, Palbociclib, and Abemaciclib in ER+/HER2- EBCWho this might be right forBreast CancerHormone Receptor-positive Breast CancerHormone Therapy National Taiwan University Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT07498478What this trial is testingEfficacy and Safety of Tinengotinib Tablets Combined With Fulvestrant Injection in Patients With HR Positive and HER-2 Negative Recurrent or Metastatic Breast Cancer Who Have Failed Prior TreatmentWho this might be right forBreast Cancer TransThera Sciences (Nanjing), Inc. 94
Testing effectiveness (Phase 2)Study completedNCT00617968What this trial is testingGETNA2 Neoadj. TAX+Femara vs Femara in g I/II Breast CancerWho this might be right forBreast Neoplasms Sanofi 5
Early research (Phase 1)Study completedNCT03099174What this trial is testingThis Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast CancerWho this might be right forNeoplasmsBreast Neoplasms Boehringer Ingelheim 133
Testing effectiveness (Phase 2)UnknownNCT02630368What this trial is testingMetronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma (METROmaJX)Who this might be right forSolid TumorsSoft-tissue SarcomaBreast Cancer Institut Bergonié 197
Testing effectiveness (Phase 2)Study completedNCT00050141What this trial is testingStudy of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast CancerWho this might be right forBreast Cancer Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 121
Testing effectiveness (Phase 2)UnknownNCT02592746What this trial is testingPalbociclib With Exemestane Plus GnRH Versus Capecitabine in Premenopausal Women With HR+ MBCWho this might be right forMetastatic Breast Cancer Samsung Medical Center 182
Not applicableLooking for participantsNCT07341503What this trial is testingThe Sleep After Breast Cancer (ABC) Study - Examining Sleep Changes and Biomarkers Among Breast Cancer PatientsWho this might be right forAnatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+2 more Ohio State University Comprehensive Cancer Center 100
Testing effectiveness (Phase 2)Study completedNCT01698918What this trial is testingOpen-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast CancerWho this might be right forHormone Receptor Positive Breast Cancer Novartis Pharmaceuticals 202